Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

The Trump administration's new COVID-19 vaccine plan limits access to high-risk groups, requiring further trials for low-risk individuals, marking a major policy shift amid scientific uncertainty and ...

The FDA's new vaccine guidelines focus on older adults, citing insufficient evidence for the need for additional COVID shots ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

The truth is that for most of that, for many Americans, we simply do not know the answer to whether or not they should be ...

We have to admit to ourselves that America is deeply divided on the policy issue of repeat COVID-19 vaccine doses or boosters ...

The FDA’s new approach to boosters could mean that kids will no longer be able to get vaccinated against the disease to begin with.

Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC has historically set vaccine recommendations, while the FDA determines which ...

Here’s how COVID-19 vaccine guidance is changing in the U.S. For people at high risk of severe COVID-19. The process of ...

A previous federal policy recommended an annual COVID shot for all Americans six months and older. Here is what the new proposal would be.

T he Trump administration's new Food and Drug Administration leaders said Tuesday they plan to limit Covid-19 booster shots ...